London-listed shares of Wise fell 10% on Friday after the money transfer group said its application to create a national trust bank in the United States was denied by regulators, amid major changes in financial policy. The U.S. Office of the Comptroller of the Currency denied Wise’s application as it was incompatible with the Federal Reserve’s new policies for payment system access; as a national trust bank, Wise sought to settle U.S. dollar payments directly with the Fed. YourDailyAnalysis flags the size of the reaction as the more telling number here: a 10% single-day drop for the denial of a specific charter application, rather than a core-business setback, signals investors saw this bid as considerably more strategically important than a routine regulatory filing.
The company’s own explanation for the denial points to a policy shift that occurred after Wise had already filed, not to any specific failing in its application. Wise said U.S. regulations for payments have changed significantly since it submitted its application in June of last year, adding: “With the Federal Reserve generally pausing account access for an uninsured trust bank, the approach in our application became non-viable.” YourDailyAnalysis treats that timeline as the most important fact in the story: Wise isn’t describing a rejection on the merits, it’s describing an application that became obsolete midstream because the regulatory ground shifted underneath it.
Wise’s pivot toward a different regulatory framework entirely gives the story a forward-looking angle beyond the denial itself. The fintech firm plans to submit a new application for a national trust bank charter under the GENIUS Act framework, which pertains to digital assets like stablecoins, and said its infrastructure is well positioned to interoperate with digital assets alongside existing payment rails. YourDailyAnalysis has been tracking this pivot as part of a broader industry pattern: fintech firms increasingly routing bank-charter ambitions through stablecoin-specific legislation like the GENIUS Act, rather than traditional trust-bank pathways, suggests Washington’s newest crypto-adjacent framework is becoming the more viable route into direct Fed access.
A separate compliance issue disclosed in the same report adds a reputational dimension that complicates a purely regulatory-timing narrative. The company said the regulator flagged a U.S. consent order from last year on compliance violations, following which Wise has strengthened its safety processes. That disclosure, arriving in the same statement as the denial, makes it harder to separate “bad timing” from “lingering compliance concerns” as the real reason regulators ultimately said no.
The dual-listed nature of Wise’s shares adds a cross-market dimension to how this news is likely to be absorbed. As a company listed in London with shares also trading via other structures, a U.S. regulatory setback of this kind creates a research and reaction gap between American and European investors, some of whom may be less immediately attuned to the significance of an OCC trust-bank denial than U.S.-based fintech-focused funds would be.
Watch for the timeline and terms of Wise’s promised new application under the GENIUS Act framework, since that filing will show whether Wise is pursuing essentially the same direct-Fed-access ambition through a different legal vehicle or scaling back its goals considerably. Your Daily Analysis regards the GENIUS Act refiling as the more consequential milestone to track than today’s share-price reaction, since it will reveal whether Wise’s underlying strategic goal, settling dollar payments without a traditional banking intermediary, survives this specific setback intact.
